Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 304-762-8 | CAS number: 94279-16-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Type of information:
- other: read across from analogue substance
- Adequacy of study:
- key study
- Study period:
- Since april 21, 1988 to june 01, 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant with international guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- -
- EC Number:
- 405-071-5
- EC Name:
- -
- Cas Number:
- -
- Molecular formula:
- C28H15N8Na3O17S3
- IUPAC Name:
- Trisodium 5-[[dihydroxy[(2-hydroxynitrosulfophenyl)azo]phenyl]azo]4-hydroxy-3-[(4-nitrophenyl)azo-2,7-naphthalenedisulfonate
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SAVO med. Versuchstierzuchten GmbH
- Weight at study initiation: ~ 120 g
- Assigned to test groups randomly: yes
- Fasting period before study:Approximately 18 hours before treatment with the test article the animals received no food but water ad libitum.
- Housing: single housed in Makrolon Type II, with wire mesh top , granulated soft wood bedding
- Diet: pelleted standard diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):21 ± 3°C
- Humidity(%): 30-70%
- Photoperiod : 12 hours cycle dark/light from artificial light at 6.00 a.m. to 6.00 p.m.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: deionized water
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- 24 +/- 2 hours for 28 days
- Post exposure period:
- 24 hours after the last application the bone marrow cells were collected for micronuclei analysis.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1000 mg/kg bw
Basis:
nominal conc.
- No. of animals per sex per dose:
- 6 animals x sex x dose (test item)
6 animals x sex x dose (positive control)
6 animals x sex x dose (negative control) - Control animals:
- no
- Positive control(s):
- - Name: Cyclophosphamide
- Route of administration: oral
- Doses / concentrations: 10 ml/kg bw
Examinations
- Tissues and cell types examined:
- bone marrow cells were collected for micronuclei analysis.
- Details of tissue and slide preparation:
- The animals were sacrificed by cervical dislocation. The femora were removed, the epiphyses were cut off and the marrow was flushed out with fetal calf serum, using a 5 ml syringe. The cell suspension was centrifuged at 1,500 rpm for 10 minutes and the supernatant was discarded. A small drop of the resuspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald (MERCK, D-6100 Darmstadt)/Giemsa (Gurr, BDH Limited Poole, Great Britain). Cover slips were mounted with EUKITT (KINDLER, D-7800 Freiburg). At least one slide was made from each bone marrow sample.
- Evaluation criteria:
- A test article is classified as mutagenic if it induces either a statistically significant dose-related increase in the number of micronucleated polychromatic erythrocytes or a reproducible statistically significant positive response for at least one of the test points.
A test article producing neither a statistically significant dose-relat-ed increase in the number of micronucleated polychromatic erythrocytes nor a statistically significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
This can be confirmed by means of the nonparametric Mann-Whitney test.
However, both biological and statistical significance should be considered together. - Statistics:
- Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
A dose of 1000 mg/kg b.w. was administered. 1000 mg/kg b.w. of the test article was close to the maximum tolerated dose. 3 out of 12 treated animals died during the 28 days period (1 male, 2 females).
Applicant's summary and conclusion
- Conclusions:
- The analogue substance was tested for in vivo micronucleus following OECD 474. Under the experiemtnal conditions test article did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the rat.
- Executive summary:
The analogue substance was tested for in vivo micronucleus following OECD 474. This study was performed to investigate the potential of the substance to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the rat.
The test article was dissolved in deionized water. This solvent was used as negative control. The volume administered orally was 10 ml/kg b.w. The animals received the test article or negative control once per 24 +/- 2 h for 28 days. 24 hours after the last application the bone marrow cells were collected for micronuclei analysis.
Ten animals (5 males, 5 females) per test group with the exception of the test article group in which only 9 animals survived (5 males and 4 females) were evaluated for the occurrence of micronuclei. 1000 polychromatic erythrocytes (PCE) per animal were scored for micronuclei.
To describe a cytotoxic effect due to the treatment with the test article the ratio between polychromatic and normochromatic erythrocytes (NCE) was determined in the same sample and reported as the number of NCE per 1000 PCE.
A dose of 1000 mg/kg b.w. was administered. 1000 mg/kg b.w. of the test article was close to the maximum tolerated dose. 3 out of 12 treated animals died during the 28 days period (1 male, 2 females).
After treatment with the test article the ratio between PCEs and NCEs was affected as compared to the corresponding negative control thus indicating a test article-dependent effect on the target cells.
In comparison to the corresponding negative controls there was neither for the females nor for the total collective of FAT 40'317/B treated animals a statistically significant enhancement in the frequency of the detected micronuclei.
An appropriate reference mutagen was administered once and used as positive control which showed a distinct increase of induced micronucleus frequency.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.